STOCK
WATCH
🇺🇸
US
·
🇮🇳
IN
English
हिन्दी
বাংলা
தமிழ்
తెలుగు
मराठी
ગુજરાતી
ಕನ್ನಡ
മലയാളം
ਪੰਜਾਬੀ
ଓଡ଼ିଆ
Home
Home
Meter
Live
Live
Reports
Reports
Login
Home
Home
Meter
Live
Live
Reports
Reports
Anika Therapeutics, Inc.
Watchlist
Ticker: 898437
Overview
P/L
Share Hold
Shareholding data MIA.
Corporate Events
Events
Quarters
No corporate events found.
Q2 FY26
Revenue
32.61
+10.1%
Net Profit
3.31
+165.4%
OPM %
9.06%
Q1 FY26
Revenue
29.61
+6.4%
Net Profit
-5.06
-117.2%
OPM %
-18.53%
Q3 FY25
Revenue
27.82
-1.4%
Net Profit
-2.33
+41.3%
OPM %
-11.62%
Q2 FY25
Revenue
28.22
+7.8%
Net Profit
-3.97
+18.5%
OPM %
-14.81%
Q1 FY25
Revenue
26.17
-32.5%
Net Profit
-4.87
+83.7%
OPM %
-16.37%
Q3 FY24
Revenue
38.75
-7.6%
Net Profit
-29.92
-33144.4%
OPM %
-72.30%
Q2 FY24
Revenue
41.92
+3.5%
Net Profit
-0.09
+98.0%
OPM %
0.38%
Q1 FY24
Revenue
40.52
-2.3%
Net Profit
-4.51
+31.5%
OPM %
-12.49%
Q3 FY23
Revenue
41.47
-6.4%
Net Profit
-6.58
-140.1%
OPM %
-18.51%
Q2 FY23
Revenue
44.30
Net Profit
-2.74
OPM %
-8.20%
Corporate Events
Events
Quarters
No corporate events found.
Q2 FY26
Revenue
32.61
+10.1%
Net Profit
3.31
+165.4%
OPM %
9.06%
Q1 FY26
Revenue
29.61
+6.4%
Net Profit
-5.06
-117.2%
OPM %
-18.53%
Q3 FY25
Revenue
27.82
-1.4%
Net Profit
-2.33
+41.3%
OPM %
-11.62%
Q2 FY25
Revenue
28.22
+7.8%
Net Profit
-3.97
+18.5%
OPM %
-14.81%
Q1 FY25
Revenue
26.17
-32.5%
Net Profit
-4.87
+83.7%
OPM %
-16.37%
Q3 FY24
Revenue
38.75
-7.6%
Net Profit
-29.92
-33144.4%
OPM %
-72.30%
Q2 FY24
Revenue
41.92
+3.5%
Net Profit
-0.09
+98.0%
OPM %
0.38%
Q1 FY24
Revenue
40.52
-2.3%
Net Profit
-4.51
+31.5%
OPM %
-12.49%
Q3 FY23
Revenue
41.47
-6.4%
Net Profit
-6.58
-140.1%
OPM %
-18.51%
Q2 FY23
Revenue
44.30
Net Profit
-2.74
OPM %
-8.20%
